Abattis Bioceuticals Corp. (QB) Stock Price - ATTBF

Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN
Abattis Bioceuticals Corp. (QB) ATTBF Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.00% 0.0287 0.03005 0.0272 0.03005 0.0287 10:33:58
Bid Price Ask Price Spread Spread % News
0.0287 0.03 0.0013 4.33% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
20 99,789 $ 0.028804 $ 2,874 485,885 0.017 - 0.1919
Last Trade Time Type Quantity Stock Price Currency
10:33:58 6,200 $ 0.0287 USD

Abattis Bioceuticals Corp. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 12.26M 427.11M $ -7.63M - -1.61 91.13M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Abattis Bioceuticals Corp. (QB) News

Latest ATTBF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ATTBF Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.02750.0340.02720.0303111k413k242k0.00124.36%
1 Month0.03870.03870.02720.0327100k463k218k-0.01-25.84%
3 Months0.030.0690.02720.045371k5M463k-0.0013-4.33%
6 Months0.050.090.0170.049571k5M595k-0.0213-42.60%
1 Year0.1440.19190.0170.097571k12M945k-0.1153-80.07%
3 Years0.03410.0150.191811015M872k-0.0053-15.59%
5 Years0.4551.390.010.196411015M600k-0.4263-93.69%

Abattis Bioceuticals Corp. (QB) Description

Abattis is a life sciences and biotechnology company which aggregates, integrates, and invests in cannabis technologies and biotechnology services for the legal cannabis industry developing in Canada. The Company has successfully developed and licensed natural health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets. The Company is also seeking to acquire exclusive intellectual property rights to agricultural technologies to be employed in extraction and processing of botanical ingredients and compounds. The Company follows strict standard operating protocols, and adheres to the applicable laws of Canada and foreign jurisdictions.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.